Association of low ankle-brachial index with mortality in patients with ischemic heart disease

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 7, 2010, Pages 759-767

  Zheng, Liqiang ^a   Li, Jue ^b   Hu, Dayi ^b   Luo, Yingyi ^c   Li, Xiankai ^b   Xu, Yuanxi ^b   Sun, Zhaoqing ^a   Sun, Yingxian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

Author keywords

Ankle brachial index; Epidemiology; Ischemic heart disease; Mortality

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGINA PECTORIS; ANKLE BRACHIAL INDEX; AREA UNDER THE CURVE; ARTERY DISEASE; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINESE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALIDITY; PREDICTOR VARIABLE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 77955784235     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.4093     Document Type: Article

References (27)

1. McDermott MM, Feinglass J, Slavensky R, Pearce WH: The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease. J Gen Intern Med, 1994; 9: 445-449
2. Heald CL, Fowkes FG, Murray GD, Price JF; Ankle Brachial Index Collaboration: Risk of mortality and cardiovascular disease associated with the ankle-brachial index: Systematic review. Atherosclerosis, 2006: 189: 61-69
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003; 289: 2560-2572
4. Diehm C, Lange S, Darius H, Pittrow D, von Stritzky B, Tepohl G, Haberl RL, Allenberg JR, Dasch B, Trampisch HJ: Association of low ankle brachial index with high mortality in primary care. Eur Heart J, 2006; 27: 1743-1749
5. Xu Y, Li J, Luo Y, Wu Y, Zheng L, Yu J, Ma J, Gu J, Hu D: The association between ankle-brachial index and cardiovascular or all-cause mortality in metabolic syndrome of elderly Chinese. Hypertens Res, 2007; 30: 613-619
6. Luo YY, Li J, Xin Y, Zheng LQ, Yu JM, Hu DY: Risk factors of peripheral arterial disease and relationship between low ankle brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with hypertension. J Hum Hypertens, 2007; 21: 461-466
7. Doobay AV, Anand SS: Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol, 2005; 25: 1463-1469
8. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV: Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation, 2004; 109: 733-739
9. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK: Major causes of death among men and women in China. N Engl J Med, 2005; 15:1124-1134
10. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2001
11. Sans S, Kesteloot H, Kromhout D; On behalf of the Task Force: The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J, 1997; 18: 1231-1248
12. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation, 1998; 97: 1837-1847
13. Brindle P, Beswick AD, Fahey T, Ebrahim SB: Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart, 2006; 92: 1752-1759
14. Ankle Brachial Index Collaboration: Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A Meta-analysis. JAMA, 2008; 300: 197-208
15. Lee AJ, Price JF, Russell MJ, Smith FB, van Wijk MC, Fowkes FG: Improved prediction of fatal myocardial infarction using the ankle brachial index in addition to conventional risk factors: the Edinburgh Artery Study. Circu lation, 2004; 110: 3075-3080
16. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, Crouse JR 3rd, Friedman L, Fuster V, Herrington DM, Kuller LH, Ridker PM, Roberts WC, Stanford W, Stone N, Swan HJ, Taubert KA, Wexler L: Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Noninvasive tests of atherosclerotic burden. Circulation, 2000; 101: E16-E22
17. Orchard TJ, Strandness DE Jr: Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association, September 18-20, 1992, New Orleans, Louisiana. Circulation, 1993; 88: 819-828
18. The American College of Cardiology foundation and the American Heart Association: ACC/AHA guidelines for the management of patients with peripheral arterial disease. Circulation, 2006; 113: 1474-1547
19. McDermott MM, Greenland P, Liu K, Guralnik JM, Celic L, Criqui MH, Chan C, Martin GJ, Schneider J, Pearce WH, Taylor LM, Clark E: The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med, 2002; 136: 873-883
20. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002; 39 (Suppl. 1): S1-S266
21. Department of Health and Human Services: The International Classification of Diseases, 9th Revision, Clinical Modification: ICD-9-CM, 3rd edn; Washington, DC: Government Printing Office, 1989
22. Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases. Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation, 2001; 104: 2746-2753
23. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel 3 guidelines. J Am Coll Cardiol, 2004; 44: 720-732
24. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN; REVERSAL Investigators: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA, 2004; 291: 1071-1080
25. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK; Treating to New Targets (TNT) Investigators: Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med, 2005; 352: 1425-1435
26. Hu D, Li J, Li X; China Cholesterol Education Program: Investigation of blood lipid levels and statin interventions in outpatients with coronary heart disease in China: the China Cholesterol Education Program (CCEP). Circ J, 2008; 72: 2040-2045
27. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U: EUROASPIRE 3: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil, 2009; 16: 121-137